24/7 Market News Snapshot 11 November, 2024 – Pyxis Oncology, Inc. Common Stock (NASDAQ:PYXS)

November 11, 2024

DENVER, Colo., 11 November, 2024 (247marketnews.com) – (NASDAQ:PYXS) are discussed in this article.
Pyxis Oncology, Inc. has demonstrated substantial momentum in the stock market, with a recent trading price of $4.95, marking an impressive gain of approximately 12.08% from a previous close at $4.42. The trading volume reached 887.91K, indicating heightened investor interest. Analysts suggest that resistance may be encountered around the $5.00 level, and if the current upward trend persists, additional gains could be on the horizon. Investors should closely monitor the evolving volume and price action as potential breakout opportunities or reversals may develop throughout the trading session.

In tandem with this market activity, Pyxis Oncology announced an upcoming investor event set for November 20, 2024, at 4:30 p.m. ET, aimed at showcasing preliminary results from its ongoing Phase 1 clinical trial for PYX-201, a groundbreaking therapeutic targeting Extradomain-B Fibronectin (EDB+FN) in solid tumors. Approximately 80 patients are being evaluated in this open-label, multicenter study, focusing on safety, efficacy, and pharmacokinetic metrics.

The event will feature insights from Pyxis Oncology’s executive management and notable thought leaders in the oncology field, including Dr. Anthony Tolcher from NEXT Oncology and Dr. Glenn Hanna of the Dana-Farber Cancer Institute. Their participation promises to enrich discussions regarding the implications of the trial findings and the prospective role of PYX-201 in cancer treatment strategies.

Stakeholders are encouraged to RSVP for both in-person and virtual attendance, with a live webcast available to ensure broader access. Pyxis Oncology remains dedicated to advancing therapeutic innovations and enhancing cancer care, positioning itself as a leader in the biotechnology sector. Interested parties can find further details in the Investor Relations section of the company’s website.

Related news for (PYXS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.